The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
MedPage Today on MSN
FDA Says to Drop Suicide Warning From GLP-1 Drug Labels
Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal ...
Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication ...
Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...
The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results